Cornerstone launches pancreatic enzyme replacement Pertzye in US

Cornerstone Therapeutics Inc., has started marketing Pertzye (pancrelipase) in the US for the treatment of Exocrine Pancreatic Insufficiency. Pertzye is the only US Food and Drug Administration approved pancreatic enzyme replacement therapy containing bicarbonate-buffered, enteric-coated microspheres. In healthy individuals, the … Continued